PROPEL Study (Lung Transplant) - Clinical Trial
Email to Participate
rachel.s.rice@duke.edu
¿Cuál es el Propósito de este estudio?
We are doing this to develop a test that could help predict a common complication after lung transplant called primary graft dysfunction (PGD). Examining the medical records of transplant recipients and their donors will help us find the data we need to create this prediction tool.
¿Cuál es la Condición que se está estudiando?
Lung Transplantation
¿Quién puede participar en el Estudio?
Adults ages 18+ who have received a lung transplant at Duke or are scheduled to have a lung transplant here.
For more information about who can join this study, please contact the study team at rachel.s.rice@duke.edu.
Grupo etario
Adultos
¿Qué Implica?
If you agree to be in this study, we will collect information from your medical records related to your lung transplant and post-transplant follow-up care. We will also collect data and samples from your lung donor, if possible.
Detalles del Estudio
Título Completo
MULTICENTER VALIDATION OF THE PROSPECTIVE REGISTRY OF OUTCOMES IN PATIENTS ELECTING LUNG TRANSPLANTATION (PROPEL) COHORT STUDY
Investigador Principal
Matthew G. Hartwig, MD
Especialista en cirugía de trasplante pulmonar
Número de Protocolo
IRB:
PRO00110217
Fase
Fase N/A
Estado de inscripción
Abierto para inscripción
Participate
Email rachel.s.rice@duke.edu